Clinical development of molecular residual disease (MRD) and multi-cancer early detection (MCED) using liquid biopsy multiomics with artificial intelligence (AI).
Shibuki T, Yamashita R, Hashimoto T, Fujisawa T, Imai M, Yuda J, Kuwata T, Misumi T, Nakamura Y, Bando H, Kojima K, Tokioka S, Chiba I, Nakaya N, Hozawa A, Koshiba S, Fuse N, Saito S, Shimizu R, Park WY, Kinoshita K, Yoshino T.
Shibuki T, et al. Among authors: imai m.
Int J Clin Oncol. 2026 Mar 6. doi: 10.1007/s10147-026-03001-6. Online ahead of print.
Int J Clin Oncol. 2026.
PMID: 41790338